NCT06199713View on ClinicalTrials.gov

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

RecruitingOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

January 30, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2029

Conditions
MelanomaMelanoma Stage IIIMelanoma Stage IVUnresectable Melanoma
Interventions
DIAGNOSTIC_TEST

18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

research scan 3-4 weeks after start of immunotherapy

Trial Locations (1)

53792

RECRUITING

University of Wisconsin Hospitals and Clinics (UWHC), Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER